Fresenius Endorses PEAK Campaign Efforts To Reduce Dialysis Patient Mortality

Main Category: Urology / Nephrology
Article Date: 22 Jun 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


Fresenius Medical Care, which operates the nation's leading network of dialysis clinics, today endorsed the Performance Excellence and Accountability in Kidney Care (PEAK) campaign recently launched by Kidney Care Partners (KCP) - a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with chronic kidney disease (CKD). The PEAK initiative is designed to significantly reduce the mortality rate for patients in their first year of dialysis.

"The PEAK initiative is consistent with our ongoing commitment to improving the quality of care," said Dr. J. Michael Lazarus, Fresenius Medical Care's chief medical officer. "Fresenius Medical Care has always emphasized quality of care in our facilities, and one area of concern has been the increased risk of death in the first year after starting dialysis treatment. Through our RightStart™ program, we were able to demonstrate that a structured program of prompt medical and educational strategies focused on patients in their first three months on dialysis does improve morbidity and mortality rates. So while we know that high mortality rates are a significant problem, we also know that if the entire kidney care community works together toward a common goal, we can make progress in this critical area."

Many factors contribute to first-year mortality among dialysis patients. Individuals starting dialysis face complex challenges, such as control of anemia, dietary changes, and vascular access management. They must also adjust to a demanding regular treatment schedule. During this transition period, patients are most susceptible to complications. PEAK is a quality improvement campaign that seeks to mitigate these challenges, pledging to extend, even save, as many as 10,000 lives and reduce mortality among first-year dialysis patients by 20 percent by the end of 2012.

"Improvements in quality of care have been at the top of the kidney care community's agenda over the past 15 years. Significant progress has been made, but the PEAK initiative raises the bar for the next 10 years," said Lazarus. "It says to patients, their families, and everyone concerned with kidney disease that there is a concrete effort in place to address real problems with actual solutions, using recommendations from leading researchers and experts. At a critical time in their lives, when the risks are greatest, dialysis patients and their families can be confident that the PEAK initiative is contributing to improving the chances for survival and a better life for all dialysis patients."

Source
Fresenius Medical Care North America

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Fresenius Medical Care North America. "Fresenius Endorses PEAK Campaign Efforts To Reduce Dialysis Patient Mortality." Medical News Today. MediLexicon, Intl., 22 Jun. 2009. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/154824.php>

APA
Fresenius Medical Care North America. (2009, June 22). "Fresenius Endorses PEAK Campaign Efforts To Reduce Dialysis Patient Mortality." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/154824.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »